Expression of KIF2A , NDC80 , CDK1 , and CCNB1 in breast cancer patients: Their interaction and linkage with tumor features and prognosis

Background Kinesin family member 2A (KIF2A), nuclear division cycle 80 (NDC80), cyclin‐dependent kinase 1 (CDK1), and cyclin B1 (CCNB1) exhibit a complex interrelation, which promote cancer progression via multiple ways, whereas their interaction and clinical implications in breast cancer are obscure. Hence, this study aimed to evaluate the correlation among KIF2A, NDC80, CDK1, CCNB1, and their linkage with clinicopathological features and prognosis in breast cancer patients. Methods 195 breast cancer patients underwent surgical resection were analyzed. KIF2A, NDC80, CDK1, and CCNB1 expressions were determined by immunohistochemical (IHC) assay and scored by a semiquantitative IHC score or positive cell percentage. Results KIF2A expression positively associated with NDC80, CDK1, and CCNB1 expressions (all p  < 0.01). In terms of tumor features: KIF2A high expression linked with increased T stage ( p  = 0.011), N stage ( p  = 0.014), and TNM stage ( p  = 0.009) but not tumor differentiation ( p  = 0.651). NDC80 high expression only related to higher N stage ( p  = 0.010); CDK1 high expression only connected with elevated N stage ( p  = 0.035) and TNM stage ( p  = 0.023). In aspect of prognosis, high expression of KIF2A was correlated with worse disease‐free survival (DFS) ( p  = 0.031), while NDC80 high ( p  = 0.329), CDK1 high ( p  = 0.276), and CCNB1 positive ( p  = 0.063) expressions only showed trends to link with poor DFS (without statistical significance). Furthermore, high expression of KIF2A ( p  = 0.063), NDC80 ( p  = 0.939), CDK1 ( p  = 0.413) and positive expression of CCNB1 ( p  = 0.296) did not relate to overall survival. Conclusion KIF2A correlates with NDC80, CDK1, CCNB1, and may link with advanced tumor stages and poor prognosis in breast cancer patients.